Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Antiplatelet therapy after PCI in patients with high risk of bleeding
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- معلومة اضافية
- بيانات النشر:
Bulgarian Pharmaceutical Scientific Society
- الموضوع:
2020
- Collection:
Pensoft Publishers
- نبذة مختصرة :
The progress of percutaneous coronary interventions (PCI) over the last few decades facilitated treatment of increasingly complex patient populations. The introduction of drug-eluting stents (DESs) led to need of stronger and prolonged inhibition of platelets which in turn increased the incidence of bleeding complications. The identification and management of patients at high bleeding risk (HBR) during and after percutaneous coronary interventions (PCI) is still problematic in everyday clinical practice.
- File Description:
text/html
- Relation:
info:eu-repo/semantics/altIdentifier/eissn/2603-557X; info:eu-repo/semantics/altIdentifier/pissn/0428-0296
- الرقم المعرف:
10.3897/pharmacia.67.e52737
- الدخول الالكتروني :
https://doi.org/10.3897/pharmacia.67.e52737
https://pharmacia.pensoft.net/article/52737/
- Rights:
info:eu-repo/semantics/openAccess
- الرقم المعرف:
edsbas.F85908B6
No Comments.